Literature DB >> 18619533

The ubiquitin-proteasome system in colorectal cancer.

Ioannis A Voutsadakis1.   

Abstract

The proteasome is a multiprotein complex that regulates the stability of hundreds of cellular proteins and thus, it is implicated in virtually all cellular functions. Most of the time, to be recognized and processed by the proteasome, a protein has to be linked to a chain of ubiquitin molecules. Cell proliferation, apoptosis, angiogenesis and motility, processes with particular importance for carcinogenesis are regulated by the ubiquitin-proteasome system (UPS). In colorectal epithelium, UPS plays a role in the regulation of the Wnt/beta-catenin/APC/TCF4 signaling which regulates proliferation of colorectal epithelial cells in the bottom of the crypts and the inhibition of this proliferation as cells move towards colon villi tips. In most colorectal cancers APC (Adenomatous Polyposis Coli) disabling mutations interfere with the ability of the proteasome to degrade beta-catenin leading to uninhibited cell proliferation. Other key molecules in colorectal carcinogenesis such as p53, Smad4 and components of the k-ras pathways are also regulated by the UPS. In this review I discuss the role of UPS in colorectal carcinogenesis and colorectal cancer prognosis and aspects of its inhibition for therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619533     DOI: 10.1016/j.bbadis.2008.06.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  31 in total

Review 1.  Physiological functions and clinical implications of the N-end rule pathway.

Authors:  Yujiao Liu; Chao Liu; Wen Dong; Wei Li
Journal:  Front Med       Date:  2016-09-07       Impact factor: 4.592

2.  Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib.

Authors:  Ioannis A Voutsadakis; Anna Patrikidou; Konstantinos Tsapakidis; Aristea Karagiannaki; Eleana Hatzidaki; Nikolaos E Stathakis; Christos N Papandreou
Journal:  Int J Colorectal Dis       Date:  2010-04-16       Impact factor: 2.571

3.  Peroxisome proliferator activated receptor-γ and the ubiquitin-proteasome system in colorectal cancer.

Authors:  Ioannis A Voutsadakis
Journal:  World J Gastrointest Oncol       Date:  2010-05-15

4.  Generation of a transgenic mouse for colorectal cancer research with intestinal cre expression limited to the large intestine.

Authors:  Yingben Xue; Robert Johnson; Marsha Desmet; Paul W Snyder; James C Fleet
Journal:  Mol Cancer Res       Date:  2010-07-27       Impact factor: 5.852

5.  Gene expression profiles of colonic mucosa in healthy young adult and senior dogs.

Authors:  Dong Yong Kil; Brittany M Vester Boler; Carolyn J Apanavicius; Lawrence B Schook; Kelly S Swanson
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

6.  Depletion of UBA protein 2-like protein inhibits growth and induces apoptosis of human colorectal carcinoma cells.

Authors:  Rui Chai; Xiaojun Yu; Shiliang Tu; Bo'an Zheng
Journal:  Tumour Biol       Date:  2016-07-25

7.  UBE2Q1 expression in human colorectal tumors and cell lines.

Authors:  Sayed Mohammad Shafiee; Atefeh Seghatoleslam; Mohsen Nikseresht; Seyed Vahid Hosseini; Mahvash Alizadeh-Naeeni; Akbar Safaei; Ali Akbar Owji
Journal:  Mol Biol Rep       Date:  2013-11-07       Impact factor: 2.316

8.  Neurotrophin NT3 promotes ovarian primordial to primary follicle transition.

Authors:  Eric Nilsson; Gretchen Dole; Michael K Skinner
Journal:  Reproduction       Date:  2009-07-07       Impact factor: 3.906

9.  A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.

Authors:  Kevin J Arvai; Ya-Hsuan Hsu; Lobin A Lee; Dan Jones
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

10.  GADD45α induction by nickel negatively regulates JNKs/p38 activation via promoting PP2Cα expression.

Authors:  Yonghui Yu; Jingxia Li; Yu Wan; Jianyi Lu; Jimin Gao; Chuanshu Huang
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.